Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, Leukaemia
Results
Other
This study was done to find out the best time to give Prevenar-13 to help prevent infections. It was for children with acute lymphoblastic leukaemia (ALL) who were having or had recently finished treatment.
The study was open for people to join between 2010 and 2014. The team published results in 2020.
Recruitment start: 3 September 2010
Recruitment end: 31 July 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Juliet Gray
NIHR Clinical Research Network: Cancer
NIHR Research for Patient Benefit (RfPB) programme
University Hospital Southampton NHS Foundation Trust
Last reviewed: 12 May 2021
CRUK internal database number: 8982
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
